510(k) · Cleared
ClearedBetacone Hip Prosthesis System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Waldemar Link GmbH & Co. KG · LWJ Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Uncemented
Cleared on Nov 18, 2005 as substantially equivalent to K930963 (Encore Orthopedics, Inc., 1994) and 4 other predicates after a 136-day review. Its family tree reaches back 4 generations to 1987.
- Decided
- Nov 18, 2005
- Review
- 136 days
- Class
- Class II
- Product code
- LWJ
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 4 generations to K871453 (1987). 7 ancestors in all. No later device cites it as a predicate yet.
- Root · 4 generations backK871453 Zweymueller-SL Hip Prosthesis StemAllo Pro Corp. · 1987
- 3 generations backK962101 Zweymueller SL Femoral Hip StemIntermedics Orthopedics · 1996
- 2 generations backK030373 Alloclassic Zweymueller SL/SLL Femoral StemCenterpulse Orthopedics, Inc. · 2003 · Recalled
- 1 generation backK033664 Modification to Alloclassic Zweymuller SL Offset Femoral StemCenterpulse Orthopedics, Inc. · 2003 · Recalled
- This deviceK051826 Betacone Hip Prosthesis SystemWaldemar Link GmbH & Co. KG · 2005
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K871453 | Zweymueller-SL Hip Prosthesis Stem | Allo Pro Corp. | 1987 | — |
| −3 | K962101 | Zweymueller SL Femoral Hip Stem | Intermedics Orthopedics | 1996 | — |
| −2 | K030373 | Alloclassic Zweymueller SL/SLL Femoral Stem | Centerpulse Orthopedics, Inc. | 2003 | 1 |
| −1 | K033664 | Modification to Alloclassic Zweymuller SL Offset Femoral Stem | Centerpulse Orthopedics, Inc. | 2003 | 1 |
| 0 (this device) | K051826 | Betacone Hip Prosthesis System | Waldemar Link GmbH & Co. KG | 2005 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1994 | 1 | 0 |
| 2001 | 1 | 0 |
| 2004 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LWJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K930963 | SL-Plus & SLR-Plus Stems W/Biolox Ceramic HeadsSummary page 2…888.3860, LWJ. Nov 17 05 12:30P Predicate Devices Encore Orthopaedics' SL-Plus and SLRt-Plus Stems (Encore) (1K930963); Centerpulse's CLS Spotorno Stems (CLS) (1(042249, K010839); Zinmmer's Alloclassic Femor… | 1994 |
| * | K042249 | CLS Spotorno StemSummary page 2…redicate Devices Encore Orthopaedics' SL-Plus and SLRt-Plus Stems (Encore) (1K930963); Centerpulse's CLS Spotorno Stems (CLS) (1(042249, K010839); Zinmmer's Alloclassic Femoral Stems (Alloclassic) (K(033664, K030373). Intended Use I… | 2004 |
| * | K010839 | CLS Varus Stem/CLS 135 StemSummary page 2…Devices Encore Orthopaedics' SL-Plus and SLRt-Plus Stems (Encore) (1K930963); Centerpulse's CLS Spotorno Stems (CLS) (1(042249, K010839); Zinmmer's Alloclassic Femoral Stems (Alloclassic) (K(033664, K030373). Intended Use I Indicati… | 2001 |
| * | K033664 | Modification to Alloclassic Zweymuller SL Offset Femoral StemSummary page 2…ore) (1K930963); Centerpulse's CLS Spotorno Stems (CLS) (1(042249, K010839); Zinmmer's Alloclassic Femoral Stems (Alloclassic) (K(033664, K030373). Intended Use I Indications for Use The BetaCone is intended for non-cemented use to r… | 2003 |
| * | K030373 | Alloclassic Zweymueller SL/SLL Femoral StemSummary page 2…930963); Centerpulse's CLS Spotorno Stems (CLS) (1(042249, K010839); Zinmmer's Alloclassic Femoral Stems (Alloclassic) (K(033664, K030373). Intended Use I Indications for Use The BetaCone is intended for non-cemented use to replace th… | 2003 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 18 years and passes through 4 companies; a new generation was cleared every 6.5 years on median.
- 3 of the 7 ancestors have a recall of any class.
- 2 other devices also cite its predicate K930963.
How does its category compare?
All LWJ devicesLWJ Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LWJ
1in 2012
2026 to Oct 25, outlined.
Median 510(k) review, days · LWJ
Too few LWJ 510(k)s in any year since 2007 to give a median.
Recalls per year · LWJ
2in 2023
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LWJ
51in 2025
MAUDE reports naming product code LWJ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 10 | 68 |
| 2008 | 1 | — | 2 | 72 |
| 2009 | 1 | — | 2 | 84 |
| 2010 | 0 | — | 0 | 132 |
| 2011 | 1 | — | 0 | 255 |
| 2012 | 1 | — | 0 | 390 |
| 2013 | 0 | — | 1 | 522 |
| 2014 | 0 | — | 0 | 452 |
| 2015 | 0 | — | 0 | 310 |
| 2016 | 0 | — | 0 | 293 |
| 2017 | 0 | — | 0 | 311 |
| 2018 | 0 | — | 0 | 227 |
| 2019 | 0 | — | 0 | 210 |
| 2020 | 0 | — | 0 | 189 |
| 2021 | 0 | — | 0 | 155 |
| 2022 | 0 | — | 0 | 91 |
| 2023 | 0 | — | 2 | 72 |
| 2024 | 0 | — | 0 | 54 |
| 2025 | 0 | — | 0 | 51 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The BetaCone is intended for non-cemented use to replace the anatomy of the femur in cases of total hip replacement. It is indicated in the treatment of the following:
• Patient conditions of noninflammatory degenerative joint disease, e.g., avascular necrosis and osteoarthritis; and inflammatory joint disease, e.g., rheumatoid arthritis;
* Those patients with failed previous surgery where pain, deformity, or dysfunction persists; and
* Revision of a previously failed hip arthroplasty.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K051826 · printed Nov 6, 2026
Cite this page
510(k) Report. “K051826: Betacone Hip Prosthesis System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051826
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026